Two new Re(I)bipyridyltricarbonylchloride complexes, Re(BB3)(CO) 3 Cl, and Re(BB4)(CO) 3 Cl, featuring BODIPY groups appended to the 5,5'-, or 6,6'-positions of the bipyridine ligand respectively, have been synthesized as structurally isomeric compliments to a previously reported 4,4'-substituted homologue, Re(BB2)(CO) 3 Cl. X-ray crystal structures of the compounds show that the 4,4'-, 5,5'-and 6,6'-substitution patterns place the BODIPY groups at progressively shorter distances of 9.43 Å, 8.39 Å and 5.56 Å, respectively, from the complexes' Re centers. The photophysical properties of the isomeric complexes were investigated to ascertain the manner in which the heavy rhenium atom might induce intersystem crossing of the pendant BODIPY moieties positioned at progressively shorter through-space distances. Electronic absorption spectroscopy revealed that the three metal complexes retain the strong visible absorption features characteristic of the bpy-BODIPY (BB2-BB4) ligands, however, the fluorescence of the parent borondipyrromethane appended ligands is attenuated by more than an order of magnitude in Re(BB2)(CO) 3 Cl and Re(BB3)(CO) 3 Cl, and by more than two orders of magnitude in Re(BB4) (CO) 3 Cl. Furthermore, phosphorescence from Re(BB4)(CO) 3 Cl is observed under a nitrogen atmosphere, consistent with highly efficient ISC to the triplet-excited state. Singlet oxygen sensitization studies confirm that all three complexes produce singlet oxygen with quantum yields that increase as the distance of the BODIPY groups to the heavy rhenium center is decreased. The trends observed across the series of rhenium complexes with respect to emission and 1 O 2 sensitization properties can be rationalized in terms of the varied distal separation between the metal center and BODIPY groups in each system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.